Atovaquonebased
Atovaquonebased refers to medications that utilize atovaquone as their primary active ingredient. Atovaquone is an antiprotozoal drug that works by inhibiting mitochondrial electron transport in susceptible organisms. This disruption of energy production is crucial for the survival of certain parasites.
The most common use of atovaquonebased medications is for the prevention and treatment of Pneumocystis pneumonia
Other indications for atovaquonebased treatments include the treatment of toxoplasmosis, another parasitic infection that can be